ImmuPharma PLC 2025 AR1

Company: ImmuPharma PLC

Sector: Health Care

Country: United Kingdom

Year: 2025

Type: AR1

Pages: 84

Back to company

ImmuPharma PLC

ImmuPharma PLC 2025 Report and Consolidated Financial Statements

Report And Consolidated Financial Statements

This annual report from ImmuPharma PLC covers the company's financial results and performance for 2025.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Jan 1, 2025 - Dec 31, 2025

Fiscal Year

2025

Type

Annual Report

Language

English

Pages

 

File Size

 

Standards & Assurance

No data available

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

No data available